Wai Yuen Tong Medicine Holdings Limited
0897
Rank in Stocks
#22590
Wai Yuen Tong Medicine Holdings Limited operates as an investment holding... Wai Yuen Tong Medicine Holdings Limited operates as an investment holding company with a multifaceted business portfolio. Its core activities encompass the production, processing, and retail distribution of traditional Chinese medicines, Western pharmaceuticals, and a range of health and personal care products. These offerings reach customers across Hong Kong, mainland China, Macau, and international markets. The company's Chinese medicine and health food lines are marketed under the Wai Yuen Tong brand, while its Western pharmaceutical and personal care items are available under the Madame Pearl's and Pearl's labels. Beyond its product-focused segments, the group also engages in property investment, ownership, and sales, provides financial services, and oversees an agricultural produce exchange. As of March 31, 2022, Wai Yuen Tong maintained 63 retail stores in Hong Kong. Founded in 1897, the company is headquartered in Kowloon Bay, Hong Kong, and operates as a subsidiary of Rich Time Strategy Limited.
Share Price
$0.0465424
Last synced: 2026-11-10
Market Cap
$51.87M
Change (1 day)
1.35%
Change (1 year)
-16.85%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Wai Yuen Tong Medicine Holdings Limited (0897)
Category
Healthcare
Operating Margin for Wai Yuen Tong Medicine Holdings Limited (0897)
Operating Margin as of November 2026 TTM: -2.36%
According to Wai Yuen Tong Medicine Holdings Limited's latest financial reports, its current operating margin (TTM) is -2.36%. At the end of 2025 the company had an operating margin of -4.25%.
Operating Margin history for Wai Yuen Tong Medicine Holdings Limited from 2004 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -2.36% | -44.47% |
| 2025 | -4.25% | -181.42% |
| 2024 | 5.22% | 30.17% |
| 2023 | 4.01% | -0.74% |
| 2022 | 4.04% | -292.38% |
| 2021 | -2.10% | -90.30% |
| 2020 | -21.66% | 10.62% |
| 2019 | -19.58% | 48.22% |
| 2018 | -13.21% | -22.29% |
| 2017 | -17.00% | 92.31% |
| 2016 | -8.84% | -551.02% |
| 2015 | 1.96% | -79.67% |
| 2014 | 9.64% | -30.50% |
| 2013 | 13.87% | 36.92% |
| 2012 | 10.13% | 43.08% |
| 2011 | 7.08% | 24.43% |
| 2010 | 5.69% | -334.16% |
| 2009 | -2.43% | -116.62% |
| 2008 | 14.62% | -831.00% |
| 2007 | -2.00% | -86.50% |
| 2006 | -14.81% | 17.63% |
| 2005 | -12.59% | 57.77% |
| 2004 | -7.98% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -108.22% |
DE
|
|
| 19.68% | -108.34% |
DE
|
|
| 13.26% | -105.62% |
JP
|
|
| 17.08% | -107.24% |
CH
|
|
| 14.92% | -106.32% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Wai Yuen Tong Medicine Holdings Limited's operating margin
What is Wai Yuen Tong Medicine Holdings Limited's operating margin?
Wai Yuen Tong Medicine Holdings Limited's operating margin is -2.36%, as of Nov 2026.
What was Wai Yuen Tong Medicine Holdings Limited's operating margin in 2025?
In 2025, Wai Yuen Tong Medicine Holdings Limited's operating margin was -4.25%, compared with 5.22% in 2024.
How has Wai Yuen Tong Medicine Holdings Limited's operating margin changed since 2020?
From 2020 to 2025, Wai Yuen Tong Medicine Holdings Limited's operating margin was highest in 2024 (5.22%) and lowest in 2020 (-21.66%).
How does Wai Yuen Tong Medicine Holdings Limited's operating margin compare with similar companies?
Wai Yuen Tong Medicine Holdings Limited's operating margin (-2.36%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.